Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 076019
Company: HOSPIRA
Company: HOSPIRA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | 500MG/VIAL | INJECTABLE;INJECTION | Prescription | AP | No | No |
| DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | 2GM/VIAL | INJECTABLE;INJECTION | Prescription | AP | No | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/17/2004 | ORIG-1 | Approval |
Letter (PDF)
Review |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/76019ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/076019_s000_DeferoxamineTOC.html |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 05/08/2025 | SUPPL-30 | Labeling-Package Insert |
Label is not available on this site. |
||
| 10/23/2023 | SUPPL-27 | Labeling-Package Insert |
Label is not available on this site. |
||
| 10/23/2023 | SUPPL-20 | Labeling-Package Insert |
Label is not available on this site. |
||
| 11/08/2016 | SUPPL-14 | Labeling-Package Insert |
Label is not available on this site. |
||
| 12/03/2009 | SUPPL-11 | Labeling |
Label is not available on this site. |
||
| 12/14/2007 | SUPPL-8 | Labeling |
Label is not available on this site. |
DEFEROXAMINE MESYLATE
INJECTABLE;INJECTION; 500MG/VIAL
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | 500MG/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 078718 | FRESENIUS KABI USA |
| DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | 500MG/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 207384 | GLAND |
| DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | 500MG/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 076019 | HOSPIRA |
| DESFERAL | DEFEROXAMINE MESYLATE | 500MG/VIAL | INJECTABLE;INJECTION | Prescription | Yes | AP | 016267 | MITEM PHARMA |
INJECTABLE;INJECTION; 2GM/VIAL
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | 2GM/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 078718 | FRESENIUS KABI USA |
| DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | 2GM/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 207384 | GLAND |
| DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | 2GM/VIAL | INJECTABLE;INJECTION | Prescription | No | AP | 076019 | HOSPIRA |